Cargando…
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
The pathophysiology of bipolar disorder remains to be elucidated and there are no diagnostic or prognostic biomarkers for the condition. In this explorative proteomic study, we analyzed 201 proteins in cerebrospinal fluid (CSF) from mood stable bipolar disorder patients and control subjects sampled...
Autores principales: | Isgren, Anniella, Göteson, Andreas, Holmén-Larsson, Jessica, Pelanis, Aurimantas, Sellgren, Carl, Joas, Erik, Sparding, Timea, Zetterberg, Henrik, Smedler, Erik, Jakobsson, Joel, Landén, Mikael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734044/ https://www.ncbi.nlm.nih.gov/pubmed/35986174 http://dx.doi.org/10.1038/s41380-022-01724-2 |
Ejemplares similares
-
A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder
por: Göteson, Andreas, et al.
Publicado: (2022) -
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls
por: Pålsson, Erik, et al.
Publicado: (2017) -
Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls
por: Zhang, Ruyue, et al.
Publicado: (2020) -
Long-term trajectory of cognitive performance in people with bipolar disorder and controls: 6-year longitudinal study
por: Sparding, Timea, et al.
Publicado: (2021) -
Cognitive Functioning in Clinically Stable Patients with Bipolar Disorder I and II
por: Sparding, Timea, et al.
Publicado: (2015)